Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ELI LILLY & CoLLY · Entity 2794 | Director | November 20, 2017 | November 22, 2017 |
| Elanco Animal Health IncELAN · Entity 3457 | Director | May 21, 2026 | May 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ELI LILLY & Co
Report date November 20, 2017 · Filed November 22, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,284 |
Reported balance
After 2017-11-20 transaction · row 1
1 source rowRow 1 · 2017-11-20 · Grant · Acquired 1,924 · Balance 36,284 |
| Common StockSEC Table I · non-derivative | IndirectSuzanne A. Hoover Revocable Trust | 1,500 |
Reported balance
Holding disclosure · report date 2017-11-20 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,500 F1: Revocable Trust of which reporting person's spouse is the trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: Revocable Trust of which reporting person's spouse is the trustee.
Elanco Animal Health Inc
Report date May 21, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 111,451 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 4,678 · Balance 111,451 F1: Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors. |
| Common StockSEC Table I · non-derivative | IndirectRevocable Trust | 150,000 |
Reported balance
Holding disclosure · report date 2026-05-21 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 150,000 |
| Common StockSEC Table I · non-derivative | IndirectSuzanne A. Hoover Revocable Trust | 15,920 |
Reported balance
Holding disclosure · report date 2026-05-21 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 15,920 |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BALL Corp
Report date April 25, 2018 · Filed April 25, 2018
Section 16 reporting ended · disclosed 2018-04-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 192,811.0889 |
Reported balance
Holding disclosure · report date 2018-04-25 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 192,811.0889 |
| Common StockSEC Table I · non-derivative | IndirectRDH Trust | 971,090 |
Reported balance
Holding disclosure · report date 2018-04-25 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 971,090 |
| Deferred Compensation Company Stock PlanSEC Table II · derivative / convertible security | Direct | 11,152.1288 |
Reported balance
Holding disclosure · report date 2018-04-25 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 11,152.1288 F1: Each unit may be settled for a single share of stock or the equivalent amount of cash pursuant to the Ball Corporation Deferred Compensation Company Stock Plan. F2: Stock units in Ball Corporation's Deferred Compensation Company Stock Plan are distributed upon the separation of service in accordance with the Plan. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 38,542 |
Reported balance
Holding disclosure · report date 2018-04-25 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 38,542 F3: Each restricted stock unit represents a contingent right to receive one share of Ball Corporation Common Stock. |
| Stock Appreciation Rights (sars)SEC Table II · derivative / convertible security · Conversion / exercise price $10.02 · Expires 2019-01-28 | Direct | 800,000 |
Reported balance
Holding disclosure · report date 2018-04-25 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 800,000 |
| Stock Appreciation Rights (sars)SEC Table II · derivative / convertible security · Conversion / exercise price $12.61 · Expires 2020-01-27 | Direct | 516,400 |
Reported balance
Holding disclosure · report date 2018-04-25 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 516,400 |
| Stock Option (iso) (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.61 · Expires 2020-01-27 | Direct | 13,600 |
Reported balance
Holding disclosure · report date 2018-04-25 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 13,600 |
Filing footnotes · ownership attribution and instrument terms
F1: Each unit may be settled for a single share of stock or the equivalent amount of cash pursuant to the Ball Corporation Deferred Compensation Company Stock Plan.
F2: Stock units in Ball Corporation's Deferred Compensation Company Stock Plan are distributed upon the separation of service in accordance with the Plan.
F3: Each restricted stock unit represents a contingent right to receive one share of Ball Corporation Common Stock.
EDGEWELL PERSONAL CARE Co
Report date February 03, 2021 · Filed February 05, 2021
Section 16 reporting ended · disclosed 2021-02-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 46,724 |
Reported balance
After 2021-02-03 transaction · row 1
1 source rowRow 1 · 2021-02-03 · Exercise / conversion · Acquired 20,839 · Balance 46,724 F1: Total of the previously deferred Restricted Stock Equivalents as reported here in Table II converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. |
| Restricted Stock EquivalentsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-02-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-02-03 · Other · Disposed 10,000 · Balance 0 F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. |
| Restricted Stock Equivalents 1-3-2017SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-02-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-02-03 · Other · Disposed 1,667 · Balance 0 F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. |
| Restricted Stock Equivalents 1-2-2018SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-02-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-02-03 · Other · Disposed 2,072 · Balance 0 F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. |
| Restricted Stock Equivalents 2-1-2019SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-02-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-02-03 · Other · Disposed 3,156 · Balance 0 F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. |
| Restricted Stock Equivalents 2-6-2020SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-02-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-02-03 · Other · Disposed 3,944 · Balance 0 F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. |
| Common StockSEC Table I · non-derivative | IndirectSuzanne A. Hoover Revocable Trust | 10,000 |
Reported balance
Holding disclosure · report date 2021-02-03 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 10,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Total of the previously deferred Restricted Stock Equivalents as reported here in Table II converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021.
F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2026 Filed May 26, 2026 20:45 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 4,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001186033-26-000002 · form4-05262026_080554.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,451 F1 · shares: Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| December 19, 2025 Filed Dec 23, 2025 21:03 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GiftCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001186033-25-000007 · form4-12232025_091249.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Revocable Trust Disclosed balance after: 150,000 F1 · kind: Reported transaction is a gift of shares to a charitable trust. Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 22:02 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 10,314 | $0.00 | $0.00 |
DisclosureSEC source: 0001186033-25-000005 · form4-12022025_101220.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,773 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:21 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 25,000 | $10.90 | $272,557.50 |
DisclosureSEC source: 0001415889-25-007410 · form4-03072025_090317.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Revocable Trust Disclosed balance after: 210,000 Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:07 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 18,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-028141 · form4-12032024_101236.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,459 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:09 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 20,000 | $16.14 | $322,808.00 |
DisclosureSEC source: 0001415889-24-007385 · form4-03082024_100353.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Revocable Trust Disclosed balance after: 185,000 Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:50 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 2,147.651 | $14.90 | $32,000.00 |
DisclosureSEC source: 0001415889-24-000324 · form4-01032024_090114.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,400.2643 Underlying: Common Stock · 2,147.651 shares Expires not disclosed F1 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F2 · security: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $14.90 on December 29, 2023. F3 · derivative.exercise_price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $14.90 on December 29, 2023. F3 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F3 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F3 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 22:28 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 20,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-015773 · form4-12042023_101231.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,290 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 20:36 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 2,846.9751 | $11.24 | $32,000.00 |
DisclosureSEC source: 0001415889-23-013883 · form4-10032023_081023.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,252.6133 Underlying: Common Stock · 2,846.9751 shares Expires not disclosed F1 · derivative.exercise_price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · derivative.exercise_price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $11.24 on September 29, 2023. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 21:16 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 3,180.9145 | $10.06 | $32,000.00 |
DisclosureSEC source: 0001415889-23-010792 · form4-07052023_090758.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,405.6382 Underlying: Common Stock · 3,180.9145 shares Expires not disclosed F1 · derivative.exercise_price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · derivative.exercise_price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $10.06 on June 30, 2023. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:31 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 3,404.2553 | $9.40 | $32,000.00 |
DisclosureSEC source: 0001415889-23-006020 · form4-04042023_080434.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,224.7237 Underlying: Common Stock · 3,404.2553 shares Expires not disclosed F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $9.40 on March 31, 2023. F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $9.40 on March 31, 2023. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 20:21 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 5,000 | $9.55 | $47,750.00 |
DisclosureSEC source: 0001415889-23-004945 · form4-03152023_080315.xml · nonDerivative · entry 2 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 165,000 Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 20:21 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 5,000 | $9.46 | $47,288.00 |
DisclosureSEC source: 0001415889-23-004945 · form4-03152023_080315.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 160,000 F1 · price: Reflects the weighted average price of 5,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on March 13, 2023 with purchase prices ranging from $9.455 to $9.4578 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 22:47 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 10,000 | $11.13 | $111,300.00 |
DisclosureSEC source: 0001415889-23-004438 · form4-03072023_100323.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 155,000 Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 22:10 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 872.8863 | $12.22 | $10,666.67 |
DisclosureSEC source: 0001415889-23-000093 · form4-01032023_100141.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,820.4684 Underlying: Common Stock · 872.8863 shares Expires not disclosed F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.22 on December 30, 2022. F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.22 on December 30, 2022. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 22:05 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 828.8011 | $12.87 | $10,666.67 |
DisclosureSEC source: 0001415889-22-011973 · form4-12022022_101200.xml · derivative · entry 4 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,947.5821 Underlying: Common Stock · 828.8011 shares Expires not disclosed F2 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F3 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F4 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.87 on November 30, 2022. F2 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F4 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.87 on November 30, 2022. F2 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 22:05 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 18,649 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-011973 · form4-12022022_101200.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,916 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 20:29 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 808.6937 | $13.19 | $10,666.67 |
DisclosureSEC source: 0001415889-22-010998 · form4-11022022_011111.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,118.781 Underlying: Common Stock · 808.6937 shares Expires not disclosed F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $13.19 on October 31, 2022. F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $13.19 on October 31, 2022. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:50 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 859.5222 | $12.41 | $10,666.67 |
DisclosureSEC source: 0001415889-22-010279 · form4-10042022_021006.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,310.0873 Underlying: Common Stock · 859.5222 shares Expires not disclosed F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.41 on September 30, 2022. F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.41 on September 30, 2022. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| September 09, 2022 Filed Sep 9, 2022 20:31 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 20,000 | $15.18 | $303,614.00 |
DisclosureSEC source: 0001415889-22-009498 · form4-09092022_010912.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 145,000 F1 · shares: Reflects the weighted average price of 20,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on September 9, 2022 with purchase prices ranging from $15.105 to $15.2599 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 31, 2022 Filed Sep 2, 2022 20:07 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 705.0013 | $15.13 | $10,666.67 |
DisclosureSEC source: 0001415889-22-009259 · form4-09022022_010912.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,450.5651 Underlying: Common Stock · 705.0013 shares Expires not disclosed F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $15.13 on August 31, 2022. F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $15.13 on August 31, 2022. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 20:37 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 526.4891 | $20.26 | $10,666.67 |
DisclosureSEC source: 0001415889-22-008120 · form4-08022022_010823.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,745.5638 Underlying: Common Stock · 526.4891 shares Expires not disclosed F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $20.26 on July 29, 2022. F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $20.26 on July 29, 2022. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 20:35 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 543.3861 | $19.63 | $10,666.67 |
DisclosureSEC source: 0001415889-22-007343 · form4-07052022_010713.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,219.0747 Underlying: Common Stock · 543.3861 shares Expires not disclosed F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $19.63 on June 30, 2022. F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $19.63 on June 30, 2022. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 23:54 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 450.0704 | $23.70 | $10,666.67 |
DisclosureSEC source: 0001415889-22-006046 · form4-06022022_040646.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,675.6886 Underlying: Common Stock · 450.0704 shares Expires not disclosed F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $23.70 on May 31, 2022. F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $23.70 on May 31, 2022. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| May 20, 2022 Filed May 24, 2022 20:33 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 10,000 | $23.33 | $233,269.00 |
DisclosureSEC source: 0001415889-22-005599 · form4-05242022_010528.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 125,000 F1 · price: Reflects the weighted average price of 10,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on May 20, 2022 with purchase prices ranging from $23.19 to $23.3393 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| April 29, 2022 Filed May 3, 2022 21:34 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 421.4409 | $25.31 | $10,666.67 |
DisclosureSEC source: 0001415889-22-004545 · form4-05032022_020555.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,225.6182 Underlying: Common Stock · 421.4409 shares Expires not disclosed F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $25.31 on April 29, 2022. F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $25.31 on April 29, 2022. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 21:53 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 408.8413 | $26.09 | $10,666.67 |
DisclosureSEC source: 0001415889-22-003754 · form4-04042022_020419.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,804.1773 Underlying: Common Stock · 408.8413 shares Expires not disclosed F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $26.09 on March 31, 2022. F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $26.09 on March 31, 2022. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| March 02, 2022 Filed Mar 2, 2022 22:51 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 5,000 | $29.00 | $145,000.00 |
DisclosureSEC source: 0001179110-22-001943 · edgar.xml · nonDerivative · entry 2 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 115,000 F2 · price: Reflects the weighted average price of 5,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on March 2, 2022 with purchase prices ranging from $28.88 to $29.12 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:51 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 5,000 | $28.66 | $143,322.50 |
DisclosureSEC source: 0001179110-22-001943 · edgar.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 110,000 F1 · price: Reflects the weighted average price of 5,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on March 1, 2022 with purchase prices ranging from $28.43 to $28.899 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 22:51 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 375.4548 | $28.41 | $10,666.67 |
DisclosureSEC source: 0001179110-22-001943 · edgar.xml · derivative · entry 5 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,395.336 Underlying: Common Stock · 375.4548 shares Expires not disclosed F3 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F4 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F5 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.41 on February 28, 2022. F4 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F5 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.41 on February 28, 2022. F3 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F3 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| January 31, 2022 Filed Feb 3, 2022 01:36 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 409.6263 | $26.04 | $10,666.67 |
DisclosureSEC source: 0001179110-22-000725 · edgar.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,019.8812 Underlying: Common Stock · 409.6263 shares Expires not disclosed F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $26.04 on January 31, 2022. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $26.04 on January 31, 2022. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 22:49 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 751.703 | $28.38 | $21,333.33 |
DisclosureSEC source: 0001179110-22-000133 · edgar.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,610.2549 Underlying: Common Stock · 751.703 shares Expires not disclosed F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.38 on December 31, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.38 on December 31, 2021. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 22:16 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 742.2871 | $28.74 | $21,333.33 |
DisclosureSEC source: 0001179110-21-010543 · edgar.xml · derivative · entry 4 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,858.5519 Underlying: Common Stock · 742.2871 shares Expires not disclosed F3 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F4 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F5 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.74 on November 30, 2021. F4 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F5 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.74 on November 30, 2021. F3 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F3 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 22:16 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 7,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-010543 · edgar.xml · nonDerivative · entry 2 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,267 F2 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 22:16 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 10,000 | $29.38 | $293,794.00 |
DisclosureSEC source: 0001179110-21-010543 · edgar.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 105,000 F1 · price: Reflects the weighted average price of 10,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on November 30, 2021 with purchase prices ranging from $29.3587 to $29.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 21:09 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 5,000 | $31.79 | $158,934.50 |
DisclosureSEC source: 0001179110-21-010212 · edgar.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 95,000 Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:30 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 471.4112 | $32.88 | $15,500.00 |
DisclosureSEC source: 0001179110-21-009769 · edgar.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,116.2648 Underlying: Common Stock · 471.4112 shares Expires not disclosed F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.88 on October 29, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.88 on October 29, 2021. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 20:19 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 486.0458 | $31.89 | $15,500.00 |
DisclosureSEC source: 0001179110-21-009147 · edgar.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,644.8536 Underlying: Common Stock · 486.0458 shares Expires not disclosed F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $31.89 on September 30, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $31.89 on September 30, 2021. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 20:19 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 464.3499 | $33.38 | $15,500.00 |
DisclosureSEC source: 0001235110-21-000026 · edgar.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,158.8078 Underlying: Common Stock · 464.3499 shares Expires not disclosed F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company;s Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $33.38 on August 31, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company;s Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $33.38 on August 31, 2021. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 20:57 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 8,000 | $31.45 | $251,592.00 |
DisclosureSEC source: 0000950138-21-000416 · edgar.xml · nonDerivative · entry 2 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 90,000 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $31.2983 to $31.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 13, 2021 Filed Aug 17, 2021 20:57 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 2,000 | $30.75 | $61,490.00 |
DisclosureSEC source: 0000950138-21-000416 · edgar.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 82,000 Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 20:46 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 425.0069 | $36.37 | $15,457.50 |
DisclosureSEC source: 0000950138-21-000404 · edgar.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,694.4579 Underlying: Common Stock · 425.0069 shares Expires not disclosed F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $36.37 on July 30, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $36.37 on July 30, 2021. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:41 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 446.8146 | $34.69 | $15,500.00 |
DisclosureSEC source: 0000950138-21-000370 · edgar.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,269.451 Underlying: Common Stock · 446.8146 shares Expires not disclosed F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $34.69 on June 30, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $34.69 on June 30, 2021. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 20:53 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 430.7949 | $35.98 | $15,500.00 |
DisclosureSEC source: 0000950138-21-000317 · edgar.xml · derivative · entry 4 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,822.6364 Underlying: Common Stock · 430.7949 shares Expires not disclosed F2 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F3 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F4 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $35.98 on May 28, 2021. F3 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F4 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $35.98 on May 28, 2021. F2 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| May 11, 2021 Filed May 12, 2021 21:54 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 25,000 | $32.44 | $811,000.00 |
DisclosureSEC source: 0000950138-21-000308 · edgar.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable trust Disclosed balance after: 70,000 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $32.3000 to $32.5699, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:55 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 526.3158 | $29.45 | $15,500.00 |
DisclosureSEC source: 0000950138-21-000246 · edgar.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,903.0367 Underlying: Common Stock · 526.3158 shares Expires not disclosed F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $29.45 on March 31, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $29.45 on March 31, 2021. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| March 31, 2021 Filed May 3, 2021 23:57 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 488.8048 | $31.71 | $15,500.00 |
DisclosureSEC source: 0000950138-21-000290 · edgar.xml · derivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,391.8415 Underlying: Common Stock · 488.8048 shares Expires not disclosed F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $31.71 on April 30, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $31.71 on April 30, 2021. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:56 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 471.6981 | $32.86 | $15,500.00 |
DisclosureSEC source: 0000950138-21-000162 · edgar.xml · derivative · entry 2 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,376.7209 Underlying: Common Stock · 471.6981 shares Expires not disclosed F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F4 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.86 on February 26, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F4 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.86 on February 26, 2021. F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 13:37 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | OtherRestricted Stock Equivalents 2-6-2020 · Derivative | 3,944 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-007992 · doc4.xml · derivative · entry 7 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,944 shares Expires not disclosed F2 · derivative.exercise_date: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. F2 · derivative.expiration_date: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 13:37 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | OtherRestricted Stock Equivalents 2-1-2019 · Derivative | 3,156 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-007992 · doc4.xml · derivative · entry 6 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,156 shares Expires not disclosed F2 · derivative.exercise_date: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. F2 · derivative.expiration_date: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.